observed persistent separation of the survival curves based on BCL2 mutation status in patients from the PRIMA study, but this did not reach statistical significance [ 39 ].
← all excerpts
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
1
—
—